16 Oct LILETTA IUD Now Approved for up to 5 years
October 16, 2018 – Allergan and Medicines360 announced that the Food and Drug Administration (FDA) has approved to extend the duration of use of LILETTA (levonorgestrel-releasing intrauterine system) for the prevention of pregnancy for up to 5 years.
Did You Know?
PAA members receive the lowest available price on the LILETTA IUD. 80% of PAA’s Women’s Health practices have purchased the LILETTA IUD through our agreement. Contact us to learn how your practice can also save on vaccines, including TDaP, Influenza, Hepatitis A and B and Meningococcal.